Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-2.98M.
ENTERPRISE VALUE (EV)
$-2.98M
Dermata Therapeutics, Inc.
Market Cap
$4.55M
Enterprise Value (EV)
$-2.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | $4.55M | $-2.98M |
| CalciMedica, Inc. (CALC)vs › | $4.53M | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | $4.14M |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.73M | $1.34M |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.28M | $306876.00 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | $1.04M |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.08M | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | $11.64M |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.00M | N/A |
Market Cap
$4.55M
Total Debt
$0.00
Cash
$7.52M
Enterprise Value
$-2.98M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
